Bleeding and thrombotic risk evaluation in patients with atrial fibrillation under coronary intervention

Bleeding and thrombotic risk evaluation in patients with atrial fibrillation under coronary intervention - BIWACO study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026694

Enrollment

450

Registered

2017-04-10

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation and ischemic heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.patients with atraial fibrillation documented with ECG 2.patientes received PCI therapy for coronary arterial stenosis 3.age; 20~95 4.More than one Risk factor including hpertension, DM and history of stoke and or Heart failure,

Exclusion criteria

Exclusion criteria: cardiogenic shock or hypotension, vulnerable ischemic stroke and bleeding, current heart failure hospitalization, a history of stent thrombosis, coexisting active tumor, poorly controlled hypertension, severe infections, severe liver injury pregnant women.

Design outcomes

Primary

Measure	Time frame
Evaluation of bleeding and systemic thrombosis events using PARIS risk score,DAPT score, ORBIT score and PRECISE-DAPT score	—

Secondary

Measure	Time frame
all cause of death, cardiovascular death, hemorrhagic events, hospitalization for heart faliure, myocardial infarction, cerebral infarction and coronary revasculization	—

Countries

Japan

Contacts

Public ContactAtsuyuki Wada

Kusatu General Hospital Division of Cardiology

wada@belle.shiga-med.ac.jp077-563-8866

Outcome results